Replies to post #191655 on Biotech Values

[DewDiligence]

FDA approves (private) Octapharma’s Nuwiq for hemophilia A:

http://finance.yahoo.com/news/fda-approves-octapharma-nuwiq-treatment-140000884.html

NUWIQ is the first B-domain deleted recombinant Factor VIII derived from a human cell-line, not chemically modified or fused with another protein, designed for the treatment of patients with Hemophilia A…